Quick Answer
GoodRx Holdings, Inc. reported Long-Term Debt of $483.26 million for fiscal year 2025.
GoodRx Holdings, Inc. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $483.26M | -0.7% |
| 2024 | $486.71M | -24.9% |
| 2023 | $647.70M | -0.6% |
| 2022 | $651.80M | -0.6% |
| 2021 | $655.86M | -0.6% |
| 2020 | $659.89M | -0.6% |
| 2019 | $663.89M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $484.11M | -0.7% | -0.2% |
| June 30, 2025 | $484.97M | -24.9% | -0.2% |
| March 31, 2025 | $485.84M | -24.9% | -0.2% |
| December 31, 2024 | $486.71M | -24.9% | -0.2% |
| September 30, 2024 | $487.59M | -24.8% | -24.5% |
| June 30, 2024 | $645.65M | -0.6% | -0.2% |
| March 31, 2024 | $646.68M | -0.6% | -0.2% |
| December 31, 2023 | $647.70M | -0.6% | -0.2% |
- GoodRx Holdings, Inc. showed a decrease of -0.7% in Long-Term Debt compared to the prior fiscal year.
- Over the 2019–2025 period, GoodRx Holdings, Inc.’s long-term debt has declined by 27.2% (from $663.89 million to $483.26 million).
- The most recent figure is from GoodRx Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: